Curriculum vitae - Complete

Current Positions

Chairman, Dept. Urology, St Vincent’s Private Hospital and Clinic

Clinical Director, Prostate Cancer Research, The Kinghorn Cancer Centre

Clinical Director, The Australian Prostate Cancer Research Centre – New South Wales

Director, St. Vincent’s Prostate Cancer Centre

Director, Australian Prostate Cancer Collaboration

Conjoint Associate Professor, Department of Surgery, University of New South Wales Australia

Clinical Associate Professor, Sydney Medical School, University of Sydney

Clinical Professor, School of Health Sciences, University of Tasmania

Tertiary Education

1978 MBBS (Hons) University of New South Wales Australia
1980 FRACS Part I
1980 VQE
1988 FRACS (Urology) Part II

Personal Statement

Prof Stricker is a chief Investigator of numerous pre-clinical and clinical research projects at St. Vincent’s Campus. His current interests are in maximising clinical outcomes, new forms of therapy and imaging and perfecting surgical techniques. He was the driving force in setting up St Vincent’s Prostate Cancer Clinical Database and Tissue Bank in conjunction with the Garvan Institute, which is currently housed at The Kinghorn Cancer Centre. These resources contain extensive clinical and pathological outcome data and have resulted in a comprehensive scientific and clinical source that has been acknowledged both nationally and internationally. Prof Stricker is a Member of the Australian Cancer Network working party that developed guidelines for the Management of Localised & Advance Prostate Cancer. This has been published and was the first evidence based publication through the network which was supported by NH&MRC. He is also the Director of the Australian Prostate Cancer Collaboration – a body that co-ordinates prostate cancer research nationally.

Clinical Training

1979 – 1981
Junior Residency - St George Hospital

1982 – 1985
General Surgical Training and Fellowship

1986 – 1988
Urological Training and Fellowship

1989
Visiting Urologist to St Vincent's Hospital, Sydney

1989 – 2001

Visiting Urologist to the Royal Hospital for Women, Sydney

1989
Visiting Urologist to St Vincent's Private Hospital, Sydney

1989 – 2001
Visiting Urologist to the Royal Hospital for Women, Sydney

1989
Visiting Urologist to St Luke's Hospital, Sydney

1993
Consultant Transplant Surgeon to St George Hospital, Sydney

2000
Conjoint Senior Lecturer University of NSW, Sydney

2004
Conjoint Associate Professor University of NSW, Sydney

2013
Clinical Associate Professor Sydney Medical School, Sydney University

2014
Clinical Professor, School of Health Sciences, University of Tasmania

Post-Fellowship Training

Impotence Surgical Training: -Bill Furlow - Nashville - Tom Lue - San Francisco Steve Wilson - Arkensaw

Pelvic Cancer Surgery: - Bill Fair, H Herr - Sloan Kettering, New York - Donald Skinner - U.S.C.   Scott Swanson - St Vincent's Hospital - Michael Lieber - St Vincent's Hospital - John Blasko - St Vincent's Hospital - Keith Kaye - Perth - Joe Oesterling - St Vincent's Hospital - Peter Scardino - St Vincent's Hospital - Bertrand Guillaneau - St Vincent's Hospital

Incontinence Surgery: - S.Raz - U.C.L.A. - open surgery - R.Appell - Memphis - collagen - E. Mcguire - Ann Arbour - slings

Stone Surgery: -J.Segura - St Vincent's Hospital - EDAP Machine - St Vincent's Hospital - Glen Preminger - St Vincent's Hospital

Ablatherm for Prostate Cancer: - Gelet - France - Vallencien - France

Laser Prostatectomy for BPH: - Peter Gilling - St Vincent's Hospital

Greenlight Laser Prostatectomy for BPH - Gordon Muir - London

Low Dose Rate Brachytherapy: - Michael Zelevsky - St Vincent's Hospital - Keith Kaye - Western Australian

Advance Sling – Paris June 2008.

Robotic Radical Prostatectomy: Vip Patel - St Vincent's Hospital - Ohio State University Medical Center - Florida Hospital

Focal Therapy – Prof. Mark Emberton UCLH London.

Membership

Urological Society of Australasia

American Urological Association

European Urological Society

Prostate Cancer Foundation of Australia

Society International d'Urologie

Royal Australian College of Surgeons

Australian Prostate Cancer Collaboration

NSW Urology Oncology Group

Positions Previously Held

Head, Prostate Cancer Group, Garvan Institute of Medical Research/St Vincent’s Hospital Campus

1998-2012 - Inaugural Director of the Prostate Cancer Foundation of Australia

Current Grants Held

2010 – 2014
NHMRC Enabling Grant (ID No. 614296). "Australian Prostate Cancer Collaboration (APCC) Bio-Resource”. Clements J, Sutherland RL, Tilley W, Risbridger G, Marshall V, Roder D, Stahl J, Gardiner F, Nicol D, Frydenberg M, Pedersen J, Stricker P

$2,000,000.00

2012 – 2013

St Vincent’s Clinic Foundation “K & A Collins” Grant. MRI Study. Stricker P

$50,000.00

2010 – 2015
Cancer Institute NSW Program Grant for Excellence in Translational Research. Personalised medicine for cancer: molecular biomarkers in clinical decision making for breast, prostate and pancreatic cancer.   CIs: Horvath LG , Kench J, Boyer M, Millar E, O’Toole S, Beith J, Grimison P. AI: Stricker P. (10/TPG/1-04)

$3.75 million

Federal Government Grant – “The Chronic Disease Prevention and Service Improvement”. Australian Prostate Cancer Research Centre NSW. Mattick J, Spigelman A, Stricker P, Hayes V, Horvath L

$5.5million  

2016 – 2017
NHMRC Project Grant – “Epigentic Changes in the Prostate Cancer Environment”. Clark S, Horvath L, Kench J, Stricker P et al. $848,954

Paul Ramsay Foundation – “Magnifi Trial”. Van Leeuwen P and Stricker P

$759,000

Paul Ramsay Foundation - “LuPSMA Trial”. Emmett L and Stricker P

$400,000 

 

Professional Experience

Open Radical Prostatectomy

Performed > 4000 cases.

Specialist in nerve sparing technique.

Mentored and trained Registrars, Fellows and Urological colleagues in nerve sparing technique.

Achieved international standard outcomes with <10% positive margins, up to 92% potency recovery and <2% long-term incontinence. These results have been presented and published in state, national and international meetings and journals.

 

Robotic Radical Prostatectomy

Commenced first robotic program in NSW at St Vincent's Private Hospital in February 2006 and currently has one of the largest series in Australia.

Performed > 1500 cases (2006 – 2015).

Fully trained robotic Surgeon - particular expertise in nerve sparing robotic surgery.

Performed the first Dr Vip Patel nerve sparing technique radical prostatectomy in NSW.

Invited presenter at the World Robotic Symposium in Ohio 2007 and in Orlando in 2008 and 2010.

Excellent results with low positive margin rate, high continence and good potency results. Presented at 2009 and 2010 Annual Urology Scientific meeting by invitation.

Accredited mentor to other surgical units (Western Australia, Queensland & New Zealand).

Associate Editor of Journal of Robotic Surgery.

Manages the Robotic Fellowship Program at St Vincent's Private Hospital.

Published personal series in EUR Urol.

 

Low Dose Rate Brachytherapy (Seeds)

Personal series of > 700 cases (1997-2015). One of the largest series in Australasia.

Results have been presented and published at national and international meetings.

Mentored and trained many of the units in Australia.

In 2001, with the support of the Urological Society of Australia arranged the acceptance of Brachytherapy as an approved item number by Medicare in the therapy for prostate cancer.

High Dose Rate Brachytherapy:

Largest personal series in Australia and one of the largest series in the world, with >500 cases performed personally (1998-2013).

Presented and published at national and international meetings.

Mentored and trained multiple Urologists in the technique.

Began the first program in 1998, being the first centre in Australia.

 

Focal Therapy (HIFU & Nanoknife)

Commenced HIFU in October 2005 – the first unit in Australia.

2013 commenced Nanoknife as a focal therapy.

One of three international sites evaluating Nanoknife focal therapy.

 

Active Surveillance

>1000 cases on active surveillance since 1999.

The largest series in Australia.

Structured program of follow-up with PSA, transperineal biopsies of the prostate and MRI scans.

 

Sexual Health Rehabilitation

Enormous experience in sexual rehabilitation and preservation and one of the acknowledged experts in Australia.

Set up one of the largest multidisciplinary sexual dysfunction clinics in the Southern Hemisphere (the Australian Centre for Sexual Health 1991-2001).

Trained Dr Michael Lowy who now has particular expertise in this area.

Investigator in the original research on Viagra on the protection of potency after radical prostatectomy surgery, being one of the highest accrual centres in the world and the largest in Australia.

Currently still involved in multiple projects pertaining to sexual rehabilitation after surgery.

 

Incontinence Therapy after Prostate Cancer Treatment

Personal series of >80 cases of insertion of artificial urinary sphincter for severe urinary incontinence.

Significant experience in the use of the ProAct Device, Invance and Advance Sling and Collagen Implant in the treatment of minor urinary incontinence.

Works in close association with a dedicated pelvic floor Physiotherapist on continence recovery.

 

Second Opinion Service

Over 20 years of experience in tailoring treatment to patient's needs.

Initiated a large multidisciplinary team for appropriate support throughout all treatments.

Offers second opinion on website: http://www.phillipstricker.com.au/my-practice/second-opinion  

 

Transperineal Grid-directed Prostate Biopsy Technique

Developed and first described this technique internationally in 1997.

Over 7,000 cases performed

Has minimised the chance of post biopsy sepsis using this technique.

Has presented and published on this technique nationally and internationally.

Has mentored and trained Urologists, Fellows and Registrars in this technique.

Invited chapter in Hinman’s Atlas of Urology 4 th edition

Magnetic Resonance Imaging and Spectroscopy (MRI/MRS):

First looked at the accuracy of this technology in prostate in 2007. In 2012 initiated several studies at St Vincent’s Campus evaluating MRI accuracy in comparison to prostate biopsies, PCA3 and prostate health index (PHI). Initial results from the study were presented at the AUA, European and Australian meetings.

International and national teacher of the role of MRI in prostate cancer.

Over five international publications (see CV Summary).

PSMA Scanning:

Initiated the first unit in NSW.

Published multiple prospective studies on the accuracy of this technology.

International & national speaker on PSMA

Publications

  1. Topical Mitomycin C Therapy for Carcinoma of the Bladder
    J Urol, 1987, Vol 128, 1164-1166
    Stricker, Grant, Holsken, Taylor
  2. Prophylactic Antibiotics for Elective TURP. Br.
    J. Urol. June 1988, Vol 61, 494-497
    Stricker, Grant
  3. Mitomycin C for Bladder Carcinoma. Long Term Follow-up
    J.Urol. 1990 (143, 34-36).
    Stricker, Grant, Hosken, Taylor
  4. The Investigation of Male Sexual Dysfunction (Review)
    Medical Journal of Australia - July 1991.
    Stricker P
  5. BCG enhances monocyte and lymphocyte mediated bladder tumour cell killing
    Br J Cancer. 1995 Apr;71(4):801-7.
    Pryor K, Goddard J, Goldstein D, Stricker P, Russell P, Golovsky D, Penny R
  6. Advances in the treatment of superficial bladder cancer: Optimising BCG Immunotherapy Case Discussions
    European Urology, Feb 1995, Supp, 32-33.
    Stricker P
  7. Antiproliferative effects of B.C.G. and Interferon A2B on human bladder cancer cells invitro
    Cancer Immunol Immunother. 1995 Nov;41(5):309-16.
    Pryor K, Stricker P, Russell P, Golovsky D, Penny R
  8. Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer
    Urology - 1996 Dec;48(6):957-61; discussion 961-2
    Stricker P, Pryor K, et.al
  9. Prostate Cancer: Don't be too casual
    Med J Aust. 1996 Mar 4;164(5):319-20.
    Stricker P
  10. Risks of self -injection therapy for impotence
    M.J.A. letter 1996; 165: 117-118.
    Millard R J , Stricker P, Lynch W et.al
  11. Management of Localised Prostate Cancer: state of the art
    Med J Aust 1998; 169 (1): 11-12.
    Frydenberg M, Duchesne G, Stricker P
  12. Prostate Cancer Diagnosis and Management
    Lancet 1997; 349: 1681–87
    Frydenberg M, Stricker P, Kaye KW
  13. Growth Factor Involvement in Progression of Prostate Cancer
    Clinical Chemistry 44:4 705–723 (1998)
    Russell P, Bennett S
  14. Elevated levels of Peritumoral chondroitin Sulfate are Predictive of poor prognosis in patients treated by Radical Prostatectomy for early stage prostate cancer.
    Cancer Res 1999, May 15, 59 (10.; 2324-8)
    Ricciardelli C, Quinn DI, Raymond WA, McCaul K, Sutherland R L, Stricker P, Grygiel J J, Sutherland R L, Marshall VR, Tilley WD, Horsfall DJ.
  15. Lower urinary tract symptoms in the male. Benign prostatic hyperplasia
    MedicineToday. February 2000: 20-33
    Kooner R and Stricker P.
  16. Prognostic significance of P53: Nuclear accumulation is localised prostate cancer treated with radical prostatectomy
    Cancer Res, March 15, 2000.
    Quinn D I, Lee C S, Head D R, Golovsky D, Brenner P ., Delprado W, Stricker P, Grygiel JJ, Sutherland R L
  17. Altered expression of Androgen receptor in the malignant epithelium and adjacent stroma is association with early relapse in prostate cancer
    Cancer Res 61:423-7. (2001).
    Henshall S.M., Quinn D I, Lee C S, Head D R, Golovsky D, Brenner P.C., Deprado W., Stricker P.D., Grygiel J J, Sutherland R.
  18. Over Expression of the cell cycle inhibitor p161NK4A in high grade intraepithelial neoplasia predicts early relapse in prostate cancer patients
    Clin Cancer Res. 2001 Mar;7(3):544-50.
    Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker P, Grygiel JJ, Sutherland RL.
  19. Frequent loss of oestrogen Receptor - B expression in prostate cancer and its association with outcome.
    Cancer Res 61:5331-5. (2001).
    A, Sutherland RL , Horvath L., Henshall S.M., Lee C S, Head D R, Quinn D I, Makela S., Delprado W., Golovsky D, Brenner P.C., O'Neill G., Kooner R, Stricker P, Grygiel ., Gustafsson J
  20. Prostate Cancer Part 1. Issues in Screening and Diagnosis
    Medicine Today. July 2001: 20-31
    Stricker P
  21. Prostate Cancer Part 2 - Options in Treatment
    Medicine Today. August 2001: 30-38
    Stricker P
  22. Implications for staging systems and predictive models. J. Clin Oncol. 19:3692-705. (2001)
    Quinn D., Henshall S.M., Haynes A.M., Brenner P.C., Kooner R., Golovsky D, Matthews J., O'Neill G.F., Turner J.J., Delprado W., Finlayson J.F., Sutherland R.L., Grygiel J J, Stricker P.D., Prognostic significance of pathological features in localised prostate cancer treated with radical prostatectomy.
  23. A study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localised prostate cancer. J.Clin. Oncol 20: 951-956. (2002).
    Graefen M, Karakiewics PI, Cagiannos I, Klein E, Kupelian P, Quinn DI, Henshall SM, Grygiel JJ, Sutherland R L, Stricker P, deKemion J, Cangiano T, Scherder F H, Wildhagen M F, Scardino PT, Kattan MW
  24. International validation of a pre-operative nomogram prostate cancer recurrence after radical prostatectomy
    J. Clin Oncol: 20: 3206- 3212 (2002 )
    M., Grygiel J J, Sutherland R.L., Stricker P.D., Klein E., Kupelian P., Skinner D.G., Lieskovsky G., Bochner B., Huland H., Hammerer P.G., Hease A., Erbersdobler A., Eastham J. A., de Kernion J., Cangiano T., Schroder F.H., Wildhagen M.F., van der Kwast T., Scardino P T, Kattan M W, Graefen Karakiewicz P I, Cagiannos I, Quinn D I, Henshall S
  25. Treatment of localised prostate cancer using a combination of HDR Iridium 192, Brachytherapy and EBRT.
    Australasian Radiology. 2003 47:152-160
    Stevens M, Stricker P, Saalfeld J et.al
  26. Prognostic significance of pre-operative factors in localised prostate cancer treated with radical prostatectomy: importance of percentage of biopsies that contain cancer and presence of biopsy perineural invasion
    Cancer April 2003 97:1884-1893
    Quinn DI, Henshall SM, Haynes AM, Winoto LFX, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner J J, Delprado W, Finalyson JF, Grygiel JJ, Sutherland R L, Stricker P.
  27. ZNT4 in the progression of prostate cancer. Oncogene 22, 6005-6012 (2003).
    Henshall SM, Afar DEH, Rasiah KK, Horvath LG, Gish K, Head DR, Caras I, Kensh JG, Ramakrishnan V, Quinn DI, Turner J J, Delprado W, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker P, Grygiel JJ, Mack D, Sutherland R L.
  28. A Pre-operative nomogram identifying prostate cancer patients with decreased risk of positive pelvic lymph nodes. Journal of Urology.2003 170:1798-1803
    Cagiannos I, Karakiewicz PI, Eastman, Ohiri, Rabbani, Juland, Kupelian, Klein, Quinn DI, Henshall SM, Grygiel JJ, Sutherland R L, Stricker P, Morash, Scardino PT.
  29. Survival analysis of genome-wide gene profiles of prostate cancers identifies new prognostic targets of disease relapse.
    Cancer Res 2003. 63:4196-4203
    Henshall SM, Afar DEH, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench J, Stricker P, Grygiel JJ, Ghandour G, Mack D, Sutherland R L.
  30. Rasiah, Phillip D. Stricker, Haynes A, Warick Delprado, Jennifer J Turner, Golovsky D, Phillip C Brenner, Gordon O'Neill, Kooner R, John J Grygiel, Robert L Sutherland, Susan M Henshall . The prognostic significance of Gleason pattern in patients with Gleason 7 prostate cancer. Cancer 2003. Dec 15; Volume 98/Number 12, 2560-5
    K.
  31. Clinical Cancer Research: January 15 2004, Vol 10, 615-625
    Horvath LG, Brenner PC, O'Neill GF, Kooner R, Stricker P, Grygiel JJ and Sutherland R L Membraneous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC-3 cellular proliferation in vitro.
  32. Radical Prostatectomy: A personal series of 700 cases over 14 years: Evolution in technique. ANZ J. Surg. 2004; 74: A1-A8
    P.Stricker, J Matthews and Haynes A.
  33. Determining predictors of insignificant cancer in Gleason sum 6 prostate cancer. ANZ J. Surg. 2004;74: A1-A8
    M.Hoch, Rasiah K, H Haxhimolla, Haynes A, and P Stricker.
  34. Solitary positive apical margin a treatment dilemma. ANZ J. Surg. 2004;74: A1-A8
    ZH Haxhimolla, SP David, Rasiah K, Haynes A, K Luo, D Golovsky and P Stricker.
  35. Identification of novel markers of prognosis in high grade intraepithelial neoplasia and early prostate cancer. ANZ J. Surg. 2004;74: A1-A8
    KRasiah K, SM Henshall, JG Kench, LG Horvarth, D Golovsky, PC Brenner, R Kooner, G O'Neill, J Turner, W Delprado, CS Lee, PD Stricker and RL Sutherland.
  36. Is year of radical prostatectomy a predictor of outcome in prostate cancer.   J Urol 171: 692-696. (2004).
    Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohiro M, Rabbani F, Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen MF, Quinn DI, Henshall SM, Grygiel JJ, Sutherland R L, Stricker P, Morash CG, Scardino PT and Kattan MW.
  37. Loss of BMP2, SMAD8 and SMAD4 expression in prostate cancer progression
    The Prostate 59: 234- 242 (2004).
    Horvath LG., Henshall SM, Kench.JG, Turner.JJ, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker P, Grygiel JJ, Sutherland R L.
  38. Membraneous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC-3 cellular proliferation in vitro
    Clinical Cancer Research: Vol 10, 615-625, January 15, 2004.
    Horvath LG, Brenner PC, O'Neill GF, Kooner R, Stricker P, Grygiel JJ and Sutherland R L
  39. Preclinical Validation of anti-TMEFF2- auristatin E-conjugated antibodies in the treatment of prostate cancer.
    Molecular Cancer Therapeutics 2004:3 (8. August 2004)
    Daniel Afar, Vinay Bhasker, Stricker P et al.
  40. Localised Prostate Cancer - Questions Patients Ask
    MedicineToday. September 2004, Volume 5, Number 9:18-32
    Adshead J, Stricker P.
  41. Efficacy and safety of Viagra in the treatment of erectile dysfunction during the first 6 months following radical prostatectomy
    European Urology Supplements 3 (2004. No 2, pg 33).
    Pierre Teillac, Stricker P et al.
  42. Int J Cancer: 113, 415-422 (2005).
    Horvath LG, Henshall SM, Lee C-S, Kench JG, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker P, Grygiel JJ and Sutherland R L Lower levels of nuclear B-catenin predict for a poorer prognosis in localized prostate cancer.
  43. Stratification by outcomes affecting response to Viagra in the treatment of erectile dysfunction during the first 6 months following radical prostatectomy.
    European Urology Supplements 3 (2004. No 2, pg 32).
    Francesco Montorsi, Stricker P et al.
  44. The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcomes
    Cancer Res 2005; 65(6. March 15, 2005).
    Asne Bauskin, David Brown, Simon Junankar, Kris Rasiah, Sarah Eggleton, Mark Hunter, Tao Liu, Dave Smith, Tamara Kuffner, Greg Pankhurst, Heiko Johnen, Pamela Russell, Wade Barret, Stricker P, John Grygiel, James Kench, Henshal Sl, Robert Sutherland, Samuel Breit.
  45. Cross sectional analysis of sexual function after prostate brachytherapy
    Urology 66377-381. (2005).
    Finney G, Haynes A-M, Cross P, Brenner PC, Stricker P.
  46. Assessing and managing benign prostatic hyperplasia.
    MedicineToday September 2005, Vol. 6, Number 9:12 22.
    Petr Macek, Dinesh Patel and Stricker P.
  47. Prognostic Impact of Positive Surgical Margins in Surgically Treated Prostate Cancer:Multi-institutional Assessment of 5831 Patients". Urology. 2005 Dec;66 (6:1245-50).
    Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker P, Klein E, Cangiano T, Schroder FH, Scardino PT, Kattan MW.
  48. Soon Lee, David Brown, Samuel Breit, John Grygiel, Horvath L, Stricker P, Robert Sutherland, Henshal Sl. Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiol Biomarkers Prev 2006;15 (4. April 2006).
    Kris Rasiah, James Kench, Margaret Gardiner-Garden, Andrew Biankin, Golovsky D, Phillip Brenner, Kooner R, Gordon O'Neill, Jennifer Turner, Warick Delprado, C.
  49. Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer. 2006 BJU International. Abstracts.
    P Macek, P Stricker, M Stevens, Jagavka Rr, V Chalasani, Haynes A, J Matthews, P Brenner, D Golovsky, R Kooner and G O'Neill.
  50. Treatment of localised prostate cancer using a combination of high dose-rate Ir-192 brachytherapy (HDRB) and external beam radiation therapy (EBRT): a 7 year experience
    BJU International. Abstracts (2006)
    M Stevens, P Stricker, J Saalfeld, P Brenner and R Kooner.
  51. Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy
    Journal of the National Cancer Institute, Vol 98, No.19, October 4 2006.
    Henshal Sl, Horvath L, David Quinn, Sarah Eggleton, John Grygiel, Stricker P, Andrew Biankin, James Kench, Robert Sutherland.
  52. Saw palmetto and lower urinary tract symptoms in men
    MedicineToday. August 2007, Vol. 8, Number 8: 71-72
    Chabert C, Maianski Z, Stricker P
  53. Approaches to Nerve Sparing Retrograde Athermal Technique
    Journal of Robotic Surgery 2008 (2) 105-133
    Stricker P
  54. Ethical Introduction of Robotic Radical Prostatectomy Surgery for an Experienced Open Surgeon
    Journal of Robotic 2008 (2) 105-133
    Stricker P
  55. Immunohistochemical Level of Unsulfated Chondroitin Disaccharides in the Cancer Stroma is an Independent Predictor of Prostate Cancer Relapse
    Cancer Epidemiol Biomarkers Prev 2008;17(9). September 2008 pg2488-97
    Sakko AJ, Butler MS, Byers S, Reinboth BJ, Stahl J, Kench JG, Horvath LG, Sutherland RL, Stricker P, Henshall SM, Marshall VR, Tilley WD, Horsfall DJ, Ricciardelli C
  56. Randomised, Double-Blind, Placebo-Controlled Study of Postoperative Nightly SildenafilCitrate for the Prevention of Erectile Dysfunction after Bilateral Nerve-Sparing Radical Prostatectomy. Int J Impot Res. 2008 Sep-Oct; 20(5): 479-86. Epub 2008 Jul 24.
    Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegal R, Montorsi F, Giuliano F, Brock G; Study Group (Stricker P).
  57. Androgen Regulation of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in Prostate Cancer. Prostate. 2008 Sep 15; 68 (13): 1421-9
    Ho LL, Kench JG, Handelsman DJ, Scheffer GL, Stricker P, Grygiel JG, Sutherland R L, Henshall SM, Allen JD, Horvath LG.
  58. HSD17B4 Overexpression, an Independent Biomaker of Poor Outcome in Prostate Cancer
    Mol Cell Endocrinol. 2008 Nov 28.
    Rasiah KK, Gardiner-Garden M, Padilla EJ, Moller G, Kench JG, Alles MC, Eggleton SA, Stricker P, Adamski J, Sutherland R L, Henshall SM, Hayes VM
  59. Stage Migration in Localised Prostate Cancer has No Impact on the Post Radical Prostatectomy Kattan Nomogram
    BJU International 2010. March 105 (5) 642-7
    Ruban Thanigasalam, Krishan Rasiah, Stricker P, Brenner P, Golovsky D, Kooner R, O’Neill G, Arul Earnest, Haynes A, Sutherland S, Henshal Sl, Horvath L.
  60. Quality of Life Three Years After Treatment for Localised Prostate Cancer: A Population-Based Study. BMJ 2009. Nov 27, 339-b4817. doc:10.1136/bmj.b4817
    Smith DP, King MT, Egger S, Berry M, Stricker P, Cozzi P, Ward J, O’Connell DL, Armstrong BK.
  61. Treatment for Localised Prostate Cancer. Medicine Today. July 2009; Vol 10 No.7: 63-66
    Charles Chabert, Stricker P.
  62. Should Experienced Open Prostatic Surgeons Convert to Robotic Surgery? The Real Learning curve for One Surgeon over 3 Years
    BJU Int: 10.1111/j. 1464-410X.2009.0958x
    Doumerc N, Yuen C, Savdie R, Bayzidur Rahman M, Rasiah K, PeBenito R, Delprado W , Matthews J, Haynes A, Stricker P
  63. A Practical Guide on PSA Testing
    Medicine Today. Nov 2009. Vol 10, Number 11
    Stricker P
  64. Prospective Comparative Analysis of Clinico-Pathological Outcomes Between Robotic Assisted and Open Radical Prostatectomy. 2009 The Authors Journal Compilation. 2009 BJU International. 103, Supplement 1, 1-48. Abstract.
    P Chen, R Thanigasalam, S Henshall, Haynes A, J Matthews and P Stricker.
  65. The Clinico-Pathological Outcome of Men Undergoing Prostatectomy with PSA < 4. 2009 The Authors Journal Compilation. 2009 BJU International. 103 Supplement 1. 1-48. Abstract.
    P Chen, R Thanigasalam, P Stricker, J Matthews, DeBenito R, Haynes A, S Henshall and Rasiah K.
  66. The Impact of Nerve Sparing Surgical Margin Status and Oncological Outcome in Radical Prostatectomy. 2010 The Authors Journal Compilation. 2010 BJU International. 105 Supplement 1. 1-38. Abstract.
    B Moore, DeBenito R, Haynes A, P Stricker.
  67. High-Risk Prostate Cancer: Comparison of 10 Year Biochemical Relapse-Free Survival Between High Dose Rate Brachytherapy and Open Radical Prostatectomy.
    2010 The Authors Journal Compilation, 2010 BJU International. 105 Supplement 1. 1-38. Abstract.
    Savdie R, Yuen C, Haynes A, DeBenito R, Rasiah K, Jagavka R, P Stricker P
  68. Robot-assisted Laparoscopic Prostatectomy: Analysis of an Experienced Open Surgeon's Learning Curve After 300 Procedures. Journal of Robotic Surgery. (2010) 3;229-234.
    N Dourmerc, Yuen C, P Stricker.
  69. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol Biomarkers Prev 19: 2611-2622
    Bianco-Miotto T, Chiam K, Buchanan G, Jindal S, Day TK, Thomas M, Pickering MA, O’Loughlin M, Ryan NK, Raymond WA, Horvath LG Kench JG, Stricker P, Marshall VR, Sutherland R L, Henshall SM, Gerald WL, Scher HI, Risbridger GP, Clements JA, Butler LM, Horsfall DJ, Tilley WD and Ricciardelli C (2010).
  70. Gene based predication of clinically localised prostate cancer progression after radical prostatectomy. J Urology 184: 1521-1528.
    Talentov D, Jatkoe TA, Boehm M, Zhang Y, Ferguson AM, Stricker P, Kattan MW, Sutherland R L, Kench JG, Wang Y, and Henshall SM (2010).
  71. Advances in the management of benign prostatic hyperplasia. Medicine Today. September 2011, Volume 12 Number 9.
    Yuen C, Stricker P.
  72. Low AZGP1 expression predicts for recurrence in margin positive, localised prostate cancer. Prostate. 2011 Nov; 71(15)
    Yip PY, Kench JG, Pebenito RP, Lee CS, Stricker P, Henshall SM, Sutherland R L and Horvath LG.
  73. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy
    BJU Int. 2011 Oct 12.
    Delprado W, Henshall SM, Sutherland R L, Kench J G, Savdie R, Horvath L, Pebenito R, Rasiah KK, Haynes AM, Chatfield M, Stricker P, Turner J J
  74. The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy. BJU Int. 2012 Feb; 109(4): 533-8
    Moore BM, Savdie R, Pebenito RA, Haynes AM, Matthews J, Delprado W, Rasiah KK, Stricker P.
  75. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer (2012)106, 638-645.
    King MT, Viney R, Smith DP,Hossain I, Street D, Savage E, Fowler S, Berry MP, Stockler M, Cozzi P, Stricker P, Ward J, Armb BK.
  76. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol.2012 188:781-785.
    Hossack T, Patel MI, Huo A, Brenner P, Yuen C, Spernat D, Mathews J, Haynes A-M, Sutherland R L and Stricker P (2012).
  77. Accuracy of primary systematic template-guided transperineal biopsy of the prostate for locating prostate cancer: A comparison with radical prostatectomy specimens
    J Urol. 2012 April
    Huo AS, Hossack T, Symons JL, Pebenito R, Delprado WJ, Brenner P, Stricker P
  78. Survival in men diagnosed with prostate cancer: 8 to 10 year outcomes from the NSW Prostate Cancer Care and Outcomes Study
    Draft Abstract for Sydney Cancer Conference 2012
    David P Smith, Dianne O’Connell, Albert Bang, Madeleine King, Martin Berry, Stricker P, Paul Cozzi, Armstrong B K
  79. A novel method of bladder neck imbrication to improve early urinary continence following robot-assisted racial prostatectomy
    J Robotic Surg: 10.1007/s11701-012-0371-2
    Beattie K, Symons J, Chopra S, Yuen C, Savdie R, Thanigasalam R, Haynes A, Matthews J, Brenner PC, Rasiah K, Sutherland R L, Stricker P (2013)
  80. Impact of percentage of positive biopsy cores on biochemical outcome in patients treated with low-dose rate (Iodine-125) brachytherapy for prostate cancer. Open Prostate Cancer J 5: 15-19.
    Yuen C, Hoassack T, Haynes A-M, Pe Benito RA, Matthews J, Fogarty G Jagavkar R, Brenner P and Stricker P (2012).
  81. Outcomes of transperineal template-guided prostate biopsy in 409 patients
    BJU 2013
    Symons JL, Huo A, Yuen CL Haynes A, Matthews J, Sutherland R L, Brenner P and Stricker P
  82. Informed prostate cancer risk- adjusted testing: a new paradigm. BJU Int. 2012 Dec;110 Suppl 4:30-4
    Stricker P, Frdenberg M, Kneebone A, Chopra S
  83. Circulating microRNAs predict biochemical recurrence in prostate cancer patients. BJC 2013
    Luke Selth, Scott Townley, Andrew Bert, Stricker P, Peter Sutherland, Horvath L, Gregory Goodall, Lisa Butler and Wayne Tilley.
  84. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int. 2013; Suppl 2:6-20   
    Thompson J, Lawrentschuk N, Frydenberg M, Thompson L and Stricker P on behalf of USANZ.
  85. Magnetic resonance imaging detects significant prostate cancer and could be used to reduce unnecessary biopsies: initial results from a prospective trial. J Urol 2013; May 8 Vol 189, Suppl 4S
    Thompson J, Stricker P, Brenner P, Moses D, Shnier R, Delprado W, Haynes, A-M, Hayen A.
  86. A multinational, multi-institutional study comparing positive surgical margin rates among 22,393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol 24 Nov 2013
    Sooriakumaran P, Srivastava A, Shariat S, Stricker P, Ahlering T, Eden C, Wiklund P, Sanchez-Salas R, Mottrie A, Lee D, Neal D, Ghavamian, Nyirady P, Nilsson A, Carlsson, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado W, Haynes A-M, Steyerberg E, Roobol M and Tewari A.
  87. Evaluation de la qualite de vie suite aux traitements actuels du cancer de prostate localize
    Progres en Urologie 2013/DOI:10.1016/j.purol.2013.08.187    
  88. Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases
    Eur Urol 2014, 64 (521-531)
    Thompson J, Egger S, Bohn M, Haynes A-M, Matthews J, Rasiah K, Stricker P
  89. Medium-term oncologic outcomes for extended versus saturation biopsy and transrectal versus transperineal biopsy in active surveillance for prostate cancer
    BJU International 2014 DOI:10.1111/bju.12858
    Thompson J, Hayden A, Landau A, Haynes AM, Kalapara A, Ischia J, Matthews J, Frydenberg M and Stricker P.
  90. Extrapostatic extension of prostatic carcinoma: Is its proximity to surgical margin or Gleason score important? BJU International 2014 DOI: 10.1111/bju.12911
    Gupta R, O’Connell R, Haynes A, Stricker P, Barrett W, Turner J J, Delprado W, Horvath L G and Kench J G
  91. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: A prospective study.
    J Urology 2014; July 192: 67-74
    Thompson J, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Bohm M, Haynes A, Hayden A and Stricker P
  92. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.
    Prostate Cancer and Prostatic Diseases 2014, 1-5
    Valerio M, Stricker P, Ahmed HU, Dickinson L, Ponsky L, Shnier R, Allen C, Emberton M
  93. Expression of E6AP and PML predicts for prostate cancer progression and cancer specific death
    Annals of Oncology Sept 2014
    Birch SE, Kench JG , Takano E , Chan P , Chan AL , Chiam K ,   Veillard A-S , Stricker P , Haupt S , Haupt Y , Horvath L and Fox S B
  94. An update on the medical management of benign prostatic hypertrophy
    Medicine Today 2014; 15(10): 72-76
    Tran M, Stricker P
  95. An update on the medical management of prostate cancer
    Medicine Today 2015; 16(1):42-48
    Tran M, Stricker P
  96. Combination of multi-parametric magnetic resonance imaging and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy
    BJU International February 2015:DOI:10.1111/bju.13090.Article of the month Jan 2016
    Tran M, Thompson J, Savdie R, Moses M, Schnier R, Brenner P, Delprado W, Boehm M, Haynes AM, Pulbrook M and Stricker P
  97. Adverse effects of androgen-deprivation therapy in prostate cancer and their management
    BJU International April 2015: 115 (S5), 3-13
    Rhee H, Gunter J H, Heathcote P, Ho K, Stricker P, Corcoran NM, Nelson CC
  98. Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy
    J Nucl Med Published June 25, 2015 as DOI:10.2967/jnumed.115.160382
    Morigi J J, Stricker S, van Leeuwen P, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L and Louise Emmett L
  99. Focal Irreversible Electroporation for Prostate Cancer: Functional Outcomes and Short-term Oncological Control. Prostate Cancer and Prostatic Diseases
    13 October 2015; DOI: 10.1038/pcan.2015.47
    Ting F, Tran M, Bohm M, Siriwardana A, Van Leeuwen P, Haynes A, Delprado W, Shnier R, and Stricker P
  100. Tumour Volume in Insignificant Prostate Cancer: Increasing the threshold is a safe approach to reduce overtreatment
    Prostate. 2015 Nov;75(15):1768-73. DOI: 10.1002/pros.23062. Epub 2015 Aug 18.
    Ting F, van Leeuwen PJ, Delprado W, Haynes AM, Brenner P, Stricker P
  101. Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the aortic bifurcation in higher risk Prostate Cancer : Early Toxicity Outcomes
    Biomed Res Int 2015; 2015:696439. DOI: 10.1155/2015/696439. Epub 2015 Oct 11.
    Hesselberg G , Fogarty G , Haydu L , Dougheney N , Stricker P
  102. Transperineal Prostate Biopsy
    Hinman’s Atlas of Urologic Surgery, 4 th edition. In Prostate: Malignancy pp. 552
    Symons J, Stricker P
  103. 68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
    BJU Int. 2016 May;117(5):732-9. DOI: 10.1111/bju.13397. Epub 2016 Jan 24.
    van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L
  104. The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer
    J Urol. 2016 May;195(5):1428-35. DOI: 10.1016/j.juro.2015.10.140. Epub 2015 Oct 31.
    Thompson JE , van Leeuwen PJ , Moses D , Shnier R , Brenner P , Delprado W , Pulbrook M , Bohm M , Haynes A, Hayen A, Stricker P
  105. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study
    J Magn Reson Imaging. 2016 Dec 19. DOI: 10.1002/jmri.25562. [Epub ahead of print]
    Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A
  106. Editorial Comment.
    J Urol. 2016 Nov 29. pii: S0022-5347(16)31863-8. DOI: 10.1016/j.juro.2016.09.137 [Epub ahead of print]
    van den Bos W, Stricker P
  107. Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer
    Prostate. 2016 Dec;76(16):1491-1500. DOI: 10.1002/pros.23233.
    Bruce HM, Stricker P, Gupta R, Savdie RR, Haynes AM, Mahon KL, Lin HM, Kench JG, Horvath LG
  108. Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer
    Aging (Albany NY). 2016 Oct 5;8(11):2702-2712. DOI: 10.18632/aging.101044.
    Kalsbeek AM, Chan EF, Grogan J, Petersen DC, Jaratlerdsiri W, Gupta R, Lyons RJ, Haynes AM, Horvath LG, Kench JG, Stricker PD, Hayes VM
  109. AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments
    Sci Rep. 2016 Jul 26;6:29906. DOI: 10.1038/srep29906.
    Penzias G, Janowczyk A, Singanamalli A, Rusu M, Shih N, Feldman M, Stricker P, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Viswanath S, Madabhushi A
  110. Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy
    Prostate Cancer. 2016;2016:3794738. DOI: 10.1155/2016/3794738.
    Ting F, Van Leeuwen PJ, Thompson J, Shnier R, Moses D, Delprado W, Stricker P
  111. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
    BJU Int. 2017 Feb;119(2):209-215. DOI: 10.1111/bju.13540.
    van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker P
  112. Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
    Prostate Cancer. 2016;2016:7105678. DOI: 10.1155/2016/7105678.
    van Leeuwen PJ, Siriwardana A, Roobol M, Ting F, Nieboer D, Thompson J, Delprado W, Haynes A, Brenner P, Stricker P
  113. Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide
    J Vasc Interv Radiol. 2016 Apr;27(4):568. DOI: 10.1016/j.jvir.2016.01.003.
    Ting F, Van Leeuwen PJ, Stricker P
  114. Enhancing active surveillance of prostate cancer: the potential of exercise medicine
    Nat Rev Urol. 2016 May;13(5):258-65. DOI: 10.1038/nrurol.2016.46. Review.
    Galvão DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger GP, Frydenberg M, Hill M, Chambers SK, Stricker P, Shannon T, Hayne D, Zopf E, Newton RU
  115. (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
    BJU Int. 2016 May;117(5):732-9. DOI: 10.1111/bju.13397.
    van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L
  116. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy
    BJU Int. 2016 Jan;117(1):48-54. DOI: 10.1111/bju.13090.
    Tran M, Thompson J, Böhm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker P
  117. Personalising prostate cancer care. Part 1. Advances in diagnosis
    Medicine Today 2017; 18(2): 29-32
    Thompson J, Wardana S, Stricker P

Books, Chapters and DVDs

1995 Tumour Markers and Flow Cytometry. Chapter in book "The Bladder". Fitzpatrick and Krane. Chapter by P.Stricker and P.Russell. Pg 385-394.

2000 July. The Australian Medical Association. "Home Medical Guide to Prostate Disorders". Consulting Editor.

2003. "Treatment of Localised Prostate Cancer". Member of the Prostate Cancer Working for Cancer Network Australia.

2004 "PSA for the General Practitioner" Book. P.Stricker and K. Phelps.

2008 "Prostate Cancer for the General Practitioner." Book P. Stricker and K.Phelps.

2008 "So I Have Prostate Cancer, What Now?" PCFA DVD

2009 "How Do You Choose" DVD. P Stricker

2010 "Intergrative Medicine for the General Practitioner" Book. Hassad and Phelps.

  Chapter on prostate cancer.

2012 Series of DVD’s – P Stricker. “Pelvic Floor Exercises, Moving Forward”,

    “Prevention & Localised Prostate Cancer”, “Advanced Prostate Cancer & Hormone

    Treatments”, Cured of Prostate Cancer – What About Quality of Life”, “Return to

    Potency after Prostate Cancer”, Prostate Cancer Treatments-Managing Side

    Effects”, Prostate Cancer – Integrative Medicine Taking Control”, Prostate Cancer

    – Urinary Control”, Advanced Prostate Cancer – Prof. Charles Myers, Prostate

    Cancer - managing the Mind”, “Robotic Surgery – The Journey”.   

2013 “Improving outcomes in robotic radical prostatectomy.” Chapter 7. Editor Vip Patel.

2014-15 “Clinical Practice Guidelines for PSA Testing & Early Management of Test-Detected Prostate Cancer” Prostate Cancer Foundation of Australia & Cancer Council Australia. NHMRC approved. Part of the expert advisory panel.

 

Symposia Convened - National and International

 

Impotence Symposium of Australasia - Operative Workshop St Vincent's Hospital - 1991. Editor of Monograph. Presentations on "Intracorporeal Pharmacotherapy - Results and Complications" - P. Stricker (T.Dean) & "Polypharmacotherapy" – P.Stricker (L.Jacobs) Convenor

Update of Urology for GP's University of NSW 1993. Presentations on Renal calculi, Prostate cancer & Impotence Convenor

Society Internationale d'Urologie 23rd Congress Meeting Sydney. 1994. Editor of daily proceedings & Presenter

Prostate Cancer Symposium - Operative Workshop St Vincent's Clinic 1995. Editor of Monograph. Presentation on "Radical Perineal Prostatectomy - St Vincent's Experience". Convenor

Impotence Management Symposia. P Stricker - Chairman of Australian Impotence Advisory Board 1995

Australian Society of Impotence Medicine Inaugural Meeting 1997. 4 Presentations & Surgical Workshop Co Convenor

Inaugural National GUOG Meeting (Leura). Presentations & Workshop on Prostate Cancer Surgery Co Convenor

Brachytherapy for Prostate Cancer Symposium with J.Blasko St Vincent's Hospital. 1997 Convenor and Demonstrated

Prostate Cancer Symposium - Presentation on Radical Prostatectomy Garvan Institute. 1999 Convenor

Benign Prostatic Hypertrophy - Laser Prostatectomy St Vincent's Hospital. 1999 Co Convenor

Prostate Cancer Update with Peter Scardino - Operative Workshop St Vincent's Hospital. 2001 Convenor

Laparoscopic Radical Prostatectomy - Operative Workshop St Vincent's Hospital. 2003 Convenor R.Kooner & P.Stricker

Brachytherapy Workshop with Michael Zelefsky - Operative Workshop St Vincent's Hospital 2005. Convenor

Robot Assisted Radical Prostatectomy with Vip Patel - Operative Workshop St Vincent's Hospital 2007.   Convenor.

MRI of the Prostate – A Multidisciplinary Symposium –   May 2012. Co-convenor.

Focal Therapy, Imaging & Biopsy Techniques with Mark Emberton Operative Workshop St Vincent’s Hospital, 2013.   Convenor.   

Beattie K and Stricker P. Prevalance of high risk features in radical prostatectomy specimens in patients who met criteria for nerve-sparing radical prostatectomy. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Thompson J and Stricker P. Comparison between the accuracy of 12, 16 and 20 core TRUS biopsy in detecting significant prostate cancer and correlation with grade and location on radical prostatectomy. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Thompson J and Stricker P. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Tran M, Jackson B, Boehm M, Haynes A-M, Stricker P, Irreversible Electroporation for Focal Prostate Cancer: Safety, Short-term Functional and Oncological Outcomes. Poster Presentation . 68 th Urological Society of Australia and New Zealand Annual Scientific Meeting 11 th – 19 th April 2015, Adelaide, South Australia

Tiwari A, Haynes A-M, Nguyen Q, Hammond G, Kench JG, Horvath LG, Stricker PD. A Prostate Cancer Biorepository meeting International Collaborative Demands. Poster Presentation. International Society for Biological and Environmental Repositories (ISBER) 2015 Annual Meeting and Exhibits 5-9 May 2015, Phoenix Arizona, USA

Tiwari S, Haynes A-M, Nguyen Q, Hammond G, Kench JG, Horvath LG, Stricker PD. The Garvan Query Application (GQA): A Comprehensive Search Engine for a Prostate Cancer Biorepository. Poster Presentation. International Society for Biological and Environmental Repositories (ISBER) 2015 Annual Meeting and Exhibits 5- 9 May 2015, Phoenix Arizona, USA

Thompson J, Shnier R, Moses D, Brenner P, Delprado W, Tran M, Ponsky L, Boehm M, Haynes A, Stricker P. Oral Presentation. Prospective study of pre-biopsy multiparametric magnetic resonance imaging (mpMRI) compared to transperineal template mapping biopsy (TTMB) for detection of clinically significant prostate cancer: is it accurate enough to guide selection of men for biopsy? Oral Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Tran M, Thompson J, Boehm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes A-M, Savdie R, Stricker P. Combination of multi-parametric magnetic resonance imaging (mp-MRI) and transperineal template-guided mapping biopsy (TTMB) of the prostate to identify candidates for hemi-ablative focal therapy. Poster Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Algohary A, Viswanath S, Prasanna P, Pahwa S, Gulani V, Moses D, Shnier R, Böhm M, Haynes A-M, Brenner P, Delprado W, Thompson J, Pulbrock M, Stricker P, Ponsky L, Madabhushi A. Quantitative assessment of T2-weighted MRI to better identify patients with prostate cancer in a screening population. Poster Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Nguyen Q, Haynes AM, Horvath L and Stricker PD. Prostate Cancer Research: From Lab Bench to Beside: A prospective from the Trenches. Poster presentation. 9 th Health Services and Policy Research Conference 7 – 9 th Dec 2015. Melbourne, Australia     

 

International and National Invited Surgeon

1993
Malaysian Urological Society

1995
Korean Urological Society

2000

Chinese Urological Society

2008

Western Australian Urological Society – Robot Assisted Radical Prostatectomy

2009

Queensland Australian Urological Society – Robot Assisted Radical Prostatectomy

Invited Presentations

1992

Australasian Urological Society Annual Meeting - Intravesical BCG. "Immunotherapy & Chemotherapy - 10 year experience"

1993

Australasian Ultrasound Society - Annual Meeting

    1.Transrectal ultrasound for prostate.

    2. Penile Duplex ultrasound.

New Zealand Urological Society -"Transurethral needle ablation of the prostate". P.Stricker, G. Coombes.

Malaysian Urological Society – Incontinence & Collagen Implant

1994

International Urological Society - 23rd Congress

    1. B.C.G. for Bladder cancer

    2.Collagen for Stress Incontinence

    3.TUNA for B.P.H.

8th Congress of World Ostomy Association – Adelaide."Sexual consequence of Surgery".

1996

Queensland Assert & Sexual Health Society Meeting. Specialised investigation of Impotence.

International Menopause Society

Symposium of male Sexual Dysfunction.

8th African Urological Society. Invited speaker "Peyronie's and side effects of injection treatment"

1997

South Australian Urological Society Meeting. Presentations on:

    1.Role of Surgery for prostate cancer

    2.Peyronie's Disease

    3.Collagen Implant for Male Incontinence

South Africa Visiting Lecturer -"Peyronie's Disease & Injection Therapy"

1998

Annual Urological Society of Australia Meeting – Adelaide. "Peyronie's Disease"

2000

Shanghai Urological Group - Shanghai China."1125 Brachytherapy for Prostate Cancer"

Asia-Pacific Urological Association Annual Meeting - Beijing China

   - Brachytherapy for Prostate Cancer

   - Prostate Cancer and Sexual Dysfunction

2001

Victorian State Urology Meeting. Presentations on:

    - Brachytherapy

    - Prostate Cancer

    - Peyronie's Disease

- Grid Biopsy

Urological Society of Australasia (USA) - Annual Scientific Meeting

"Medico Legal Aspect of Prostate Cancer"

Australian Prostate Cancer Collaboration (APCC) ASM.

"Nomogram Validation for Prostate Cancer"

2002

Annual Australian Urological Meeting. Presentation on Prostate Cancer

NSW Urology Meeting. Presentation on Prostate Cancer.

National Prostate Cancer Symposium. Presentation on Prostate Cancer

2003

American Urological Association (AUA) Meeting - 2 presentations

Australian Annual Scientific Urology Meeting - 7 presentations

APCC - presentation on Prostate Cancer

Australian Brachytherapy Society -"Outcomes of High & Low Dose Brachytherapy"

Sloan Kettering Prostate Cancer Meeting - "Prostate Cancer Outcomes"

Eli Lilly Company Meeting -"Prostate Cancer & Erectile Dysfunction"

National Prostate Cancer Symposium -"Prostate Cancer & Surgery"

2004

Australian Brachytherapy Society - 2 presentations

Urological Society of Australasia - 2 presentations

Uro-Oncology Group of NSW - "Radical Prostatectomy"

Sydney University - Debate on Prostate Cancer

NSW Urology Meeting - 3 presentations

Australian-Israeli Chamber of Commerce - presentation on Prostate Cancer

2005

Australasian Urological Society - 2 presentations

Chinese Urological Society - 2 presenations

St Vincent's Hospital "Steggles" Conference

Brachytherapy Symposium - 4 presentations

Asia Pacific Uro-Oncology Meeting - presentation on "HIFU"

World Health Organisation Symposium Paris -Presentation on Prostate Cancer.

NSW Urological Society Meeting - 2 presentations

2006

Australasian Urological Society - 3 presentations

NSW Urological Society Meeting - 4 presentations

7th National Prostate Cancer Symposium Melbourne

Presentation on "HIFU"

2007

Australasian Urological Society - 2 presentations

General Practitioners Continuing Education Annual Meeting - 3 presentations

Urology Oncology Group Meeting - 2 presentations

2nd International Robotic Symposium Ohio - 1 presentation

PCFA Men's Health Promotion Forum – Prostate cancer treatment panel – radical prostatectomy (open, robotic & laparoscopic).

NSW Nurses Urological Society meeting – Topic: Prostate Cancer. October  

2008

3rd International Robotic Symposium Orlando - 2 presentations. March

Laverty Pathology Men's Health Conference for GPs -   Topic: Prostate Cancer.

Nurses Surgical Symposium Westmead Hospital – “Prostatectomy & Robotic Surgery”.

General Practitioner's Continuing Education Annual Meeting – Prostate cancer & PSA.

Prostate Cancer Foundation of Australia Hunter Region

Western Australian Urological Society National Annual Scientific Meeting -3 presentations.

Prostate Cancer Foundation of Australia 1st National Conference, Gold Coast "Future of Prostate Cancer".

2009

18th Australasian Brachytherapy Group Annual Scientific Meeting, Gold Coast -1 presentation.

Australasian Urological Annual Meeting. Gold Coast - 3 presentations

2010

Australasian Urological Society Annual Meeting Perth -2 presentations and debate: "Robotic Assisted Laparoscopic Radical Prostatectomy is the Gold Standard Surgical Treatment for Prostate Cancer".

5 th International Robotic Symposium Orlando.   “Continence after robot radical prostatectomy”.

Integrative Medicine Society Meeting. “Integrative prostate cancer treatment” & “Robotics in prostate cancer surgery.”

11 th National Prostate Cancer Symposium Melbourne. August. “Continece post robotic radical prostatectomy”.

New Zealand Urological Meeting. “Prostate Cancer - How to choose” & “Robotic surgery”.

PCFA National Conference. “Prostate Cancer – How to choose” & “Side effects management”.

2011

NSW Section Urological Meeting, Sydney, November Point Counterpoint – Locally Advanced Prostate Cancer.

NSW Urological Nurses Conference, Sydney "How does one make a choice between different prostate cancer treatment modalities and robotic surgery".

12th Australasian Prostate Cancer Conference (APCC), Melbourne, August. Master class in robotic surgery.

Trainee Week 2011 "Localised Prostate Cancer – What We Do Know, What We Don’t". Factors in favour of robotic radical prostatectomy surgery.

General Practitioner Annual Symposium, Sydney, May.

1. Prostate cancer update

2. Benign prostatic hyperplasia update

The Inaugural international prostate cancer symposium – Weill Cornell Medical College New York.

1. Locally advanced prostate cancer

2. Benefits of robotic radical prostatectomy.

American Urological Society Annual Scientific Meeting. Washington, May.

1. Quality of Life

2. Transperineal biopsy of prostate

3. Locally advanced prostate cancer.

2012

GlaxoSmithKline Australia Pty Ltd GP Dinner, March. "STEP UP – Do more for your patients with BPH".

Friends of Israel Urological Symposium Tel Aviv May.

1. Learning curve of robot assist prostatectomy.

2. Nerve sparing radical prostatectomy – How do I do it -Bladder neck dissection and dissection of seminal vesicles.

NSW State Parliament Sydney. “Prostate cancer update”.

MRI of the Prostate – A Multidisciplinary Symposium. May. Sydney

1. The role of MRI

2. Screening and MRI

The Australian Vietnamese Health Professionals Association NSW Inc. – Annual Scientific Conference. October. Sydney.   PSA & Prostate Cancer Update.   

2013

3rd Congress of Asian Pacific Prostate Society (APSS) – 13 th April. Melbourne

      “How to improve continence & potency after robot-assisted radical prostatectomy”.

St Vincent’s Campus Steggles Conference – April. Sydney

1. Focal therapy – Are we ready?

2. Biopsy techniques – TRUS v’s Transperineal

3. 2 live cases presentation (Nanoknife & HIFU)

2014

USANZ 67 th Annual Scientific Meeting– The role of MRI in the early detection of prostate cancer

The role of MRI – Asia Pacific Imaging meeting

USANZ South Australian state section meeting – presentations on MRI & Focal therapy

USANZ NSW state section meeting – presentations on salvage radical prostatectomy, MRI, Nanoknife.

Tolmar lecture series – Focal therapy

Prostate cancer update – CME   GP talk September

2015

AUA New Orleans May

1. BAUS/BJUI/USANZ – The role of focal therapy in localized prostate cancer, preliminary Australian results

2. MRI presentations.  

Cleveland Clinic & Case Western Reserve University Ohio – May

1. Transperineal biopsies

2. Focal therapy

3. MRI

RANZCR NSW Branch Education evening – An update of MRI in prostate cancer

NSW State Section Meeting – 7 th November   2 presentations

1. Focal therapy

2. Overview of prostate cancer imaging

Royal Australasian College of Surgeons NSW – 10 th November Graham Coupland Lecture – “The Challenge of Prostate Cancer Care – Past, Present & Future”

2016

1. USANZ Annual Scientific Meeting. MRI Education Course –all day course, Focal Therapy Debate

2. Euroean Meeting EAU. Two Papers on PSMA PET SCanning

3. Asia-Pacific Prostate Cancer Annual Meeting. New MRI Nomogram for PC

4. Israel FOI International Meeting. Nanoknife Update , Surgery versus Radiation Debate , Robotic RP Technique

5. AUA. Focal Therapy , How to select

6. Webinar – Diet and Prostate Cancer

 

Professional Contributions

Chief investigator of numerous pre-clinical and clinical research projects at St Vincent's Campus.

In 1994 established the St Vincent's Prostate Cancer Clinical Database and Tissue Bank in conjunction with the Garvan Institute. These contain extensive clinical and pathological outcome data and have resulted in a comprehensive scientific and clinical source that has been acknowledged both nationally and internationally.

Instigated the establishment of the St Vincent's Hospital Prostate Cancer Group.

Education and mentoring of other Urologists and Urology Fellows in the area of prostate cancer treatments and procedures.

Prostate cancer grants for NHMRC - Reviewer

Cancer Council "Localised Prostate Cancer" book - Member of review committee for both editions.

"Your Guide to Prostate Cancer" by Dr Prem Rashid - Member of peer review group.

Member of the Australian Cancer Network working party that developed guidelines for the Management of Localised & Advanced Prostate Cancer. This has been published and was the first evidence based publication through the network.   

   This was supported by the NHMRC.

Regularly reviews manuscripts on prostatic conditions especially prostate cancer for peer reviewed journals including Medical Journal of Australia, Medicine Australia, Australian Prescriber,J.Urol, MJA, Eur Urology.

Research Supervisor for PhD/Masters students - Dr's David Quinn, Lisa Horvarth, Kris Rasiah, Ruban Thanigasalam, Kim Pryor, Andy Huo, James Symons, Richard Savdie and James Thompson.

Supervisor of the Urology Fellow program at St Vincent's campus.

Co-author with Prof. Kerryn Phelps of the first national "PSA for the General Practitioner" book. This book was distributed to all GP's in Australia in 2004. An updated edition was written in 2008.

Regular contributor to the "St Vincent's Clinic Proceedings" Magazine on new developments and treatments for prostatic conditions.

Advisor to the NSW Cancer Council (book reviews).

Member of PSA review board – PCFA & NHMRC.

 

Public Contributions

Prostate Cancer Support Network

Along with Jayne Matthews was involved in the initiation of the first prostate cancer support group in Australia at St Vincent's Hospital, Sydney. Has also been instrumental in the development of the Association of Prostate Cancer Support Groups throughout Australia and incorporating this in the Prostate Cancer Foundation of Australia.

Invited guest speaker at many prostate cancer support groups in NSW and ACT.

Guest speaker at the Inaugural NSW Men's Health Promotion Conference organised by the Prostate Cancer Foundation of Australia.

 

Public Education Information Brochures

Active member in an educational sense on prostate cancer issues through frequent contributions to newsletters, tapes/DVD's and a series of books. "Lifebuoy" - St Vincent's Campus prostate cancer support group newsletter and "Prostate News" - The Prostate Cancer Foundation of Australia.

AMA prostate cancer guidelines.

DVD for prostate cancer information for support groups (PCFA & personal).

Cancer Council booklet on Prostate cancer.

Television, Radio and Newspaper Interviews/Articles

Invited guest speaker on several community programs to discuss new developments in prostate cancer such as:

-Television: 60 Minutes-Channel 9, "What's Good for You",“A Current Affair” and Prime Time News on all TV stations.

- Radio: 2GB, John Laws, Dr John D'Arcy and ABC Radio national

- Newspapers: Financial Review and the Sydney Morning Herald

 

Website Service

Developed the official website for the St Vincent's Prostate Cancer Centre

  www.prostate.com.au, phillipstricker.com.au .

 

General Practitioner Education

"PSA for the General Practitioner" - Co author with Prof. Kerryn Phelps. This book was distributed to all G.P's throughout Australia.

GPCE (General Practitioner Continuing Education) Annual Conference - regular invited speaker at the National Conference for GP's held annually.

Invited guest speaker at numerous GP groups both in metropolitan and rural areas.

"Prostate Cancer for the General Practitioner" PSA Booklet Edition 2. Co-authored with Prof. Kerryn Phelps. This book was distributed to 21,500 GP's and Specialists throughout Australia (2008).

 

Prostate Cancer Foundation of Australia

Inaugural Director

Been integral in raising funds and establishing policy as a Foundation member of the organisation.

Contributed to the national "Be A Man" campaign to raise awareness of prostate cancer in the community.

 

Urology Nurses Education

Along with the nurses at St Vincent's Private Hospital, has constructed a diploma course in Urology, particularly in prostate cancer. This diploma course is now conducted annually.

Invited guest speaker at several NSW & Australian Urology Nurses Society conferences on prostate cancer treatments.

 

Research Fellows Supervised

Michael Hoch (France)

Petr Macek (Czech Republic)

Ziv Maianski (Israel)

Ruban Thanigasalam

Can Huynh

Paul Chen

Carlo Yuen

Richard Savdie

Nicolas Doumerc (France)

James Symons (2012)

Tania Hossack (2012)

James Thompson (2012)

Lee Ponsky (USA) (2013)

Minh Tran (2014)

Pim Van Leeuwen (The Netherlands) (2015)

Francis Ting (2015)
James Thompson PhD (2017)

Anton Kalsbeek  PhD (2017)

Amila Siriwadarna Masters (2017)

 

Registrars Trained

Stuart Ehsman

Peter Nash

Graham Coombes

Justin Vass

Paul Kovac

Paul Gassner

Ramin Samali

Michael Wines

Hodo Hoximollo

Jim Adshead

Venu Chalasani

Charles Chabert

Can Huynh

Claire Whelan

Anthony Hutton

About Phillip

Phillip is the Chairman of the Department of Urology, St Vincent's Private Hospital and Clinic since 2003, and a Director of the St Vincent's Prostate Cancer Centre.

The Australian Prostate Cancer Research Centre in New South Wales recently appointed him as clinical director. He is also a member of the National Prostate Cancer Research Centre

Philip is currently the highest volume robotic surgeon in Australasia

He is perhaps best known for his work developing nerve sparing techniques to help patients maximise potency